Premier Research and InSilicoTrials Partner to Leverage In Silico Modeling and Simulation and Optimize Regulatory Pathways for Rare Disease Therapies

MORRISVILLE, N.C. and MILAN and TRIESTE, Italy, March 13, 2023 /PRNewswire/ — Premier Research, whose mission is to help the most innovative biotech and device companies take their best ideas from concept to commercialization, and InSilicoTrials, a leader in the use of artificial intelligence (AI) and computational modeling and simulation (CM&S) to accelerate development of new therapies and medical devices, have partnered to create safer, faster, and more efficient pathways to regulatory approval for rare disease treatments.
More info >>